About Resonacle Pharma
Resonacle Pharma is a company. Resonacle Pharma offers products and services including Resonafer 20mg/ml and Retramic Inj 5ml.
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Resonacle Pharma Pvt Ltd
- Jurisdiction Navi Mumbai, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
-$8.4 K (USD)-2837.68as on Mar 31, 2020
-
EBITDA
-$8.07 K (USD)-2103.84as on Mar 31, 2020
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Resonacle Pharma
Resonacle Pharma offers a comprehensive portfolio of products and services, including Resonafer 20mg/ml and Retramic Inj 5ml.
Iron Sucrose injection is provided for treating iron deficiency, ensuring safety and efficacy through strict quality controls.
Tranexamic Acid injection is supplied for managing bleeding conditions, with adherence to international regulatory standards.
Funding Insights of Resonacle Pharma
Detailed funding history for Resonacle Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Resonacle Pharma
Investment portfolio details for Resonacle Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Resonacle Pharma
Detailed financials for Resonacle Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Resonacle Pharma Comparisons
Peer comparison for Resonacle Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Resonacle Pharma
Detailed competitors of Resonacle Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Resonacle Pharma
Complete news archive for Resonacle Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Resonacle Pharma
Resonacle Pharma is identified as a 100 export-oriented pharmaceutical company that supplies quality healthcare solutions globally, focusing on generic drugs and injectable products. Strategic ties with WHO-compliant manufacturers are maintained to ensure products are delivered effectively to markets like Uzbekistan, Russia, Kazakhstan, Africa, and the Middle East. Quality and compliance standards are upheld through rigorous processes, emphasizing efficacy, safety, and purity in all offerings. Partnerships are formed to address unmet medical needs and enhance access to treatments, contributing to improved patient outcomes worldwide, though no supplies are made in India.
Resonacle Pharma offers Resonafer 20mg/ml and Retramic Inj 5ml.